Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane Gangatharan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 10, 2013
Relapsed and refractory aggressive NHL: time for a changeShane Gangatharan, John Kuruvilla
BMJ Case Reports|October 15, 2018
Unusual case of unilateral conductive hearing loss: chronic lymphocytic leukaemiaAmelia Leigh Davis, Shane Gangatharan, Jafri Kuthubutheen
British Journal of Haematology|May 31, 2013
Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chainsDenise Lee, Anna Kalff, Michael Low, et al.
Internal Medicine Journal|March 5, 2025
Haematological malignancies during pregnancy: a systematic review of necessary services in the Australian contextLuke Cassidy, Antonia Shand, Joanne M Said, et al.
British Journal of Haematology|March 14, 2024
Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance studyKate Manos, Leonid Churilov, Andrew Grigg, et al.
Hemasphere|January 26, 2026
Blinatumomab in de novo AYA ALL-Results of the Australasian Leukaemia and Lymphoma Group ALL09 "SUBLIME" studyMatthew Greenwood, Shane Gangatharan, Michael Osborn, et al.
Internal Medicine Journal|December 26, 2023
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignanciesAshlea Campbell, Benjamin Teh, Stephen Mulligan, et al.
Internal Medicine Journal|May 17, 2020
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemicPietro Di Ciaccio, Georgia McCaughan, Judith Trotman, et al.
Internal Medicine Journal|May 28, 2021
COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statementGeorgia McCaughan, Pietro Di Ciaccio, Michelle Ananda-Rajah, et al.
American Journal of Hematology|March 10, 2016
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practiceArtur Jurczyszyn, Norbert Grzasko, Alessandro Gozzetti, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 10, 2013
Relapsed and refractory aggressive NHL: time for a changeShane Gangatharan, John Kuruvilla
BMJ Case Reports|October 15, 2018
Unusual case of unilateral conductive hearing loss: chronic lymphocytic leukaemiaAmelia Leigh Davis, Shane Gangatharan, Jafri Kuthubutheen
British Journal of Haematology|May 31, 2013
Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chainsDenise Lee, Anna Kalff, Michael Low, et al.
Internal Medicine Journal|March 5, 2025
Haematological malignancies during pregnancy: a systematic review of necessary services in the Australian contextLuke Cassidy, Antonia Shand, Joanne M Said, et al.
British Journal of Haematology|March 14, 2024
Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance studyKate Manos, Leonid Churilov, Andrew Grigg, et al.
Hemasphere|January 26, 2026
Blinatumomab in de novo AYA ALL-Results of the Australasian Leukaemia and Lymphoma Group ALL09 "SUBLIME" studyMatthew Greenwood, Shane Gangatharan, Michael Osborn, et al.
Internal Medicine Journal|December 26, 2023
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignanciesAshlea Campbell, Benjamin Teh, Stephen Mulligan, et al.
Internal Medicine Journal|May 17, 2020
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemicPietro Di Ciaccio, Georgia McCaughan, Judith Trotman, et al.
Internal Medicine Journal|May 28, 2021
COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statementGeorgia McCaughan, Pietro Di Ciaccio, Michelle Ananda-Rajah, et al.
American Journal of Hematology|March 10, 2016
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practiceArtur Jurczyszyn, Norbert Grzasko, Alessandro Gozzetti, et al.
Pageof 1